According to GlobalData’s medical device pipeline database, 13 Otoscopes devices are in various stages of development globally. GlobalData’s report Otoscopes provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, eight are in active development, while the remaining five are in an inactive stage of development. There are five products in the early stages of development, and the remaining three are in the late stages of development.
Otoscopes are used to examine the interior of the ear, especially the eardrum. Standard otoscopes and video otoscopes have been tracked under this category.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Otoscopes pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Otoscopes devices. Overall, most of these Otoscopes pipeline devices are being developed by private entities.
Key players involved in the active development of Otoscopes include Audioptics Medical, BioOptico, Carl R. Woese Institute for Genomic Biology, Children's National Hospital, Massachusetts Eye and Ear Infirmary, Massachusetts Institute of Technology, OtoNexus Medical Technologies, PhotoniCare Inc, Precision Optics Corporation and University of Illinois.
For a complete picture of the developmental pipeline for Otoscopes devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.